Volume 65, 2022-10-1, Pages i-179 (October)
Articles in this issue:
1. Editorial Board
2. Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D
- Pages 32-40.
- Graffeo, R., Rana, H.Q., Conforti, F., Bonanni, B., Cardoso, M.J., Paluch-Shimon, S., Pagani, O., Goldhirsch, A., Partridge, A.H., Lambertini, M., and Garber, J.E..
- PDF
3. Anthracyclines in the treatment of early breast cancer friend or foe?
- Pages 67-76.
- Vuger, Ana Tecic, Tiscoski, Katsuki, Apolinario, Thiago, and Cardoso, Fatima.
- PDF
4. A nested case-control study on radiation dose-response for cardiac events in breast cancer patients in Germany
- Pages 1-7.
- Baaken, Dan, Merzenich, Hiltrud, Schmidt, Marcus, Bekes, Inga, Schwentner, Lukas, Janni, Wolfgang, Wöckel, Achim, Mayr, Manfred, Mose, Stephan, Merz, Thomas, Ghilescu, Voica, Renner, Jona, Bartkowiak, Detlef, Wiegel, Thomas, Blettner, Maria, Schmidberger, Heinz, and Wollschläger, Daniel.
- PDF
5. Breast cancer patients’ most important quality of life themes for a radiotherapy decision aid
- Pages 8-14.
- Roumen, Cheryl, Hasannejadasl, Hajar, Swart, Rachelle, Raphael, Daniela, Wee, Leonard, Sloep, Matthijs, van den Bongard, Desiree H.J.G., Verkooijen, Helena, Thijssen, Salina, Velting, Mirjam, Schuurman, Maaike, Russell, Nicola S., Fijten, Rianne, and Boersma, Liesbeth J..
- PDF
6. Germline landscape of BRCAs by 7-site collaborations as a BRCA consortium in Turkey
- Pages 15-22.
- Bisgin, Atil, Sag, Sebnem Ozemri, Dogan, Muhammet E., Yildirim, Mahmut S., Gumus, Aydeniz Aydin, Akkus, Nejmiye, Balasar, Ozgur, Durmaz, Ceren D., Eroz, Recep, Altiner, Sule, Alemdar, Adem, Aliyeva, Lamia, Boga, Ibrahim, Cam, Fethi S., Dogan, Berkcan, Esbah, Onur, Hanta, Abdullah, Mujde, Cem, Ornek, Cemre, Ozer, Sinem, Rencuzogullari, Cagla, Sonmezler, Ozge, Bozdogan, Sevcan Tug, Dundar, Munis, and Temel, Sehime G..
- PDF
7. A systematic assessment of online international breast density information
- Pages 23-31.
- Nickel, Brooke, Copp, Tessa, Li, Tong, Dolan, Hankiz, Brennan, Meagan, Verde, Angela, Vaccaro, Lisa, McCaffery, Kirsten, and Houssami, Nehmat.
- PDF
8. The role of postoperative radiation therapy in stage I–III male breast cancer: A population-based study from the surveillance, epidemiology, and End Results database
- Pages 41-48.
- Wu, Peiwen, He, Dongjie, Zhu, Shuchai, Chang, Hao, Wang, Qiming, Shao, Qiuju, and Li, Gaiyan.
- PDF
9. Radiation recall dermatitis induced by COVID-19 vaccination in breast cancer patients treated with postoperative radiation therapy
- Pages 49-54.
- Vinante, Lorenzo, Caroli, Angela, Revelant, Alberto, Bertini, Federica, Giroldi, Anna, Marson, Marta, Franchin, Giovanni, Muraro, Elena, Brisotto, Giulia, Steffan, Agostino, and Baboci, Lorena.
- PDF
10. Risk of ipsilateral breast tumor recurrence and contralateral breast cancer in patients with and without TP53 variant in a large series of breast cancer patients
- Pages 55-60.
- Guo, Yonghai, Wan, Qiting, Ouyang, Tao, Li, Jinfeng, Wang, Tianfeng, Fan, Zhaoqing, and Xie, Yuntao.
- PDF
11. Irregular screening participation increases advanced stage breast cancer at diagnosis: A population-based study
- Pages 61-66.
- Ding, L., Greuter, M.J.W., Truyen, I., Goossens, M., De Schutter, H., de Bock, G.H., and Van Hal, G..
- PDF
12. Automated coronary artery calcium scoring in patients with breast cancer to assess the risk of heart disease following adjuvant radiation therapy
- Pages 77-83.
- Kim, Kangpyo, Chung, Seung Yeun, Oh, Caleb, Cho, Iksung, Kim, Kyung Hwan, Byun, Hwa Kyung, Yoon, Hong In, Oh, Jaewon, and Chang, Jee Suk.
- PDF
13. Progression-free survival and quality of life in metastatic breast cancer: The patient perspective
- Pages 84-90.
- Mertz, Shirley, Benjamin, Christine, Girvalaki, Charis, Cardone, Antonella, Gono, Paulina, May, Suepattra G., Comerford, Erin, Than, Kyi-Sin, Birch, Kelly, Roach, Meaghan, Myers, Sky, Sasane, Medha, Lavi, Liat, Cameron, Anna, and Cardoso, Fatima.
- PDF
14. Cost-effectiveness of trastuzumab biosimilar combination therapy and drug wastage as first-line treatment for HER2-positive metastatic breast cancer
- Pages 91-97.
- Leung, John Hang, Tai, Yun-sheng, Wang, Shyh-Yau, Yip Fion, Hei-Tung, Tsung-chin, Ho, and Chan, Agnes LF..
- PDF
15. Dual-phase FDG PET/CT for predicting prognosis in operable breast cancer
- Pages 98-103.
- Ikejiri, Haruka, Sasada, Shinsuke, Emi, Akiko, Masumoto, Norio, Kadoya, Takayuki, and Okada, Morihito.
- PDF
16. Simple oncoplastic breast defect closure improves long-term cosmetic outcome of breast conserving surgery for breast cancer: A randomised controlled trial
- Pages 104-109.
- Hadjittofi, Christopher, Almalki, Hend, Mirshekar-Syahkal, Bahar, Pain, Simon, Zechmeister, Katalin, and Hussien, Maged.
- PDF
17. Efficacy of neoadjuvant treatment with or without pertuzumab in patients with stage II and III HER2-positive breast cancer: a nationwide cohort analysis of pathologic response and 5-year survival
- Pages 110-115.
- van der Voort, Anna, Liefaard, Marte C., van Ramshorst, Mette S., van Werkhoven, Erik, Sanders, Joyce, Wesseling, Jelle, Scholten, Astrid, Vrancken Peeters, Marie Jeanne T.F.D., de Munck, Linda, Siesling, Sabine, and Sonke, Gabe S..
- PDF
18. The circulating tumor DNA (ctDNA) alteration level predicts therapeutic response in metastatic breast cancer: Novel prognostic indexes based on ctDNA
- Pages 116-123.
- Liu, Binliang, Hu, Zheyu, Ran, Jialu, Xie, Ning, Tian, Can, Tang, Yu, and Ouyang, Quchang.
- PDF
19. Evaluation of physician performance using a concurrent-read artificial intelligence system to support breast ultrasound interpretation
- Pages 124-135.
- Lai, Yi-Chen, Chen, Hong-Hao, Hsu, Jen-Feng, Hong, Yi-Jun, Chiu, Ting-Ting, and Chiou, Hong-Jen.
- PDF
20. Efficacy of taxanes rechallenge in first-line treatment of early metastatic relapse of patients with HER2-negative breast cancer previously treated with a (neo)adjuvant taxanes regimen: A multicentre retrospective observational study
- Pages 136-144.
- Vasseur, Antoine, Carton, Matthieu, Guiu, Severine, Augereau, Paule, Uwer, Lionel, Mouret-Reynier, Marie-Ange, Levy, Christelle, Eymard, Jean-Christophe, Ferrero, Jean-Marc, Leheurteur, Marianne, Goncalves, Anthony, Robert, Marie, De La Motte Rouge, Thibault, Bachelot, Thomas, Petit, Thierry, Debled, Marc, Grinda, Thomas, Desmoulins, Isabelle, Vanlemmens, Laurence, Nicolaï, Vincent, Simon, Gaëtane, and Cabel, Luc.
- PDF
21. Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer
- Pages 145-150.
- Viansone, A., Pellegrino, B., Omarini, C., Pistelli, M., Boggiani, D., Sikokis, A., Uliana, V., Zanoni, D., Tommasi, C., Bortesi, B., Bonatti, F., Piacentini, F., Cortesi, L., Camisa, R., Sgargi, P., Michiara, M., and Musolino, A..
- PDF
22. Survival in HIV+ and HIV− women with breast cancer treated at the National Cancer Institute in the city of Rio de Janeiro, Brazil, between 2000 and 2014
- Pages 151-156.
- Ferreira, Mariana Pinto, Santos Thuler, Luiz Claudio, Soares, Marcelo A., Soares, Esmeralda A., and Bergmann, Anke.
- PDF
23. Cognitive function is well preserved in a cohort of breast cancer survivors: Roles of cognitive reserve, resilience, and general health
- Pages 157-163.
- Liesto, Sanna, Sipilä, Reetta, Hietanen, Marja, and Kalso, Eija.
- PDF
24. Rising incidence of late stage breast cancer after COVID-19 outbreak. Real-world data from the Italian COVID-DELAY study
- Pages 164-171.
- Mentrasti, Giulia, Cantini, Luca, Vici, Patrizia, D'Ostilio, Nicola, La Verde, Nicla, Chiari, Rita, Paolucci, Vittorio, Crocetti, Sonia, De Filippis, Chiara, Pecci, Federica, Di Lisa, Francesca Sofia, Traisci, Donatella, Cona, Maria Silvia, Nicolardi, Linda, Pizzuti, Laura, Gildetti, Simona, Oldani, Simone, Della Mora, Arianna, Bruno Rocchi, Marco Luigi, and Berardi, Rossana.
- PDF
25. Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma®) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+ metastatic breast cancer (KCSG BR 18–14/KM10B)
- Pages 172-178.
- Sim, Sung Hoon, Kim, Jeong Eun, Kim, Min Hwan, Park, Yeon Hee, Kim, Jee Hyun, Suh, Koung Jin, Koh, Su-Jin, Park, Kyong Hwa, Kang, Myoung Joo, Ahn, Mi Sun, Lee, Kyoung Eun, Kim, Hee-Jun, Ahn, Hee Kyung, Kim, Han Jo, Park, Keon Uk, Byun, Jae Ho, Park, Jin Hyun, Lee, Gyeong-Won, Lee, Keun Seok, Sohn, Joohyuk, Jung, Kyung Hae, and Park, In Hae.
- PDF
26. Family history of breast cancer, mammographic breast density and breast cancer risk: Findings from a cohort study of Korean women
- Pages 180-186.
- Mai Tran, Thi Xuan, Kim, Soyeoun, Song, Huiyeon, and Park, Boyoung.
- PDF
27. The Canadian Task Force on Preventive Health Care should not receive high ranking based on AGREEII or GRADE
- Pages 179-179.
- Gordon, Paula B..
- PDF